Effects of methotrexate treatment on serum immunoreactivity of a patient with normal-pressure glaucoma

American Journal of Ophthalmology

Volumn 127, Issue 6, 1999, Pages 724-725

  Fellman, Ronald L ^a   Tezel, Gülgün ^a,b   Wax, Martin B ^b  

^a Glaucoma Associates of Texas   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; METHOTREXATE;

AGED; ARTICLE; CASE REPORT; FEMALE; GLAUCOMA; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; OPTIC DISK; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SJOEGREN SYNDROME; VISUAL FIELD DEFECT;

EID: 0033030757     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00020-3     Document Type: Article

References (5)

1. Cartwright M.J., Grajewski A.L., Friedberg M.L., Anderson D.R., Richards D.W. Immune-related disease and normal-tension glaucoma. Arch Ophthalmol. 110:1992;500-502.
2. Wax M.B., Barrett D.A., Pestronk A. Increased incidence of paraproteinemia and autoantibodies in patients with normal pressure glaucoma. Am J Opthalmol. 117:1994;561-568.
3. Wax M.B., Tezel G., Saito I., et al. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal pressure glaucoma. Am J Ophthalmol. 125:1998;145-157.
4. Olsen N.J., Murray L.M. Antiproliferative effects of methotrexate on peripheral blood mononuclear cells. Arthritis Rheum. 32:1989;378-385.
5. Rodriguez-Moreno J., del Blanco-Barnusell J., Castano-Moreno C., Nolla-Sole J.M., Roig-Escofet D. Systemic rheumatoid vasculitis after discontinuation of methotrexate therapy. J Rheumatol. 19:1992;1.